Provided by Tiger Trade Technology Pte. Ltd.

VolitionRX

0.2130
-0.0220-9.36%
Post-market: 0.2118-0.0012-0.56%19:46 EST
Volume:1.30M
Turnover:288.56K
Market Cap:28.88M
PE:-0.93
High:0.2430
Open:0.2400
Low:0.2120
Close:0.2350
52wk High:0.9400
52wk Low:0.1700
Shares:135.57M
Float Shares:92.35M
Volume Ratio:0.44
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2288
EPS(LYR):-0.3117
ROE:-730.06%
ROA:-148.34%
PB:-0.83
PE(LYR):-0.68

Loading ...

VolitionRx reports progress on Capture-Seq, Nu.Q lung cancer reimbursement, and Nu.Q NETs sepsis program in France

Reuters
·
Feb 25

VolitionRX Issues Unregistered Shares to Lind Global Asset Management XII LLC

Reuters
·
Feb 21

VolitionRX Appoints MBL as Distributor for Nu.Q Discover Assays in Japan

Reuters
·
Feb 10

VolitionRx Faces NYSE American Non-Compliance Notice Over Equity Requirements

Reuters
·
Feb 10

VolitionRX Receives Notice of Non-Compliance With Nyse American Continued Listing Standards

THOMSON REUTERS
·
Feb 10

VolitionRx Unveils Clinical Study Showing Nu.Q NETs Blood Test Guides Hidradenitis Suppurativa Treatment

Reuters
·
Feb 04

VolitionRX Limited Announces the Preparation of Reimbursement Submission for Its Nu.q® Cancer Assays

THOMSON REUTERS
·
Jan 30

VolitionRX Ltd: Once Reimbursement Achieved Anticipate Introduction of Nu.q Into Routine Clinical Use in France by Q4, 2026

THOMSON REUTERS
·
Jan 30

VolitionRx Unveils Study Supporting Nu.Q NETs Blood Test for Hidradenitis Suppurativa Management

Reuters
·
Jan 28

Volition Announces Data to Support Use of Nu.q® Nets in New Indication

THOMSON REUTERS
·
Jan 27

VolitionRX Ltd. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 27

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 21

VolitionRX Expands Nu.Q Vet Cancer Test Access With New Laboratory Providers

Reuters
·
Jan 20

VolitionRX Ltd. Showcases Nu.Q Vet Cancer Test at VMX Veterinary Conference

Reuters
·
Jan 16

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 09

BRIEF-Volitionrx Ltd Enters Amended Securities Purchase Agreement

Reuters
·
Jan 08

VolitionRX Ltd - Enters Amended Securities Purchase Agreement

THOMSON REUTERS
·
Jan 08

VolitionRX Ltd - to Receive $2,000,000 From Investor

THOMSON REUTERS
·
Jan 08

Press Release: VolitionRx Secures $2.0 Million in Funding

Dow Jones
·
Jan 08

VolitionRX Ltd. unveils corporate deck highlighting cancer and sepsis diagnostics, licensing strategy, and global commercialization plans

Reuters
·
Jan 08